Stoplos One 5 mg/100ml Infusion
$32.69
$19.26
Stoplos One 5 mg/100ml infusion is a specialized bisphosphonate medication designed to effectively manage a range of bone-related conditions, including osteoporosis, Paget's disease, and hypercalcemia linked to cancer and multiple myeloma. By promoting increased bone density and inhibiting the excessive breakdown of bone tissue, Stoplos One helps alleviate the symptoms associated with these serious diseases. This infusion works by minimizing the release of calcium from the bones into the bloodstream, thereby stabilizing calcium levels and supporting overall bone health. Patients should be aware of potential side effects, such as gastrointestinal discomfort and rare kidney issues, making it crucial to discuss individual health conditions with a healthcare provider prior to treatment. Administered under medical supervision, Stoplos One plays a vital role in enhancing the quality of life for those affected by debilitating bone disorders. Its unique formulation ensures that it meets the therapeutic needs of patients while prioritizing safety and efficacy. For anyone seeking relief from the challenges posed by bone diseases, Stoplos One represents a reliable option in modern treatment regimens. Always consult your healthcare professional to determine if Stoplos One is the right choice for your specific medical needs.
Quantity
Active Pharmaceutical Ingredient
Uses
• Stoplos one 5 mg 100ml infusion is utilized to manage hypercalcemia, particularly when associated with cancer. This condition results in elevated calcium levels in the blood, which can lead to various symptoms such as fatigue, nausea, and confusion. By administering Stoplos one, healthcare providers aim to lower these calcium levels effectively. This treatment is crucial for improving patient comfort and preventing complications related to high calcium levels.
• The infusion is also indicated for treating Paget's disease, a disorder that disrupts normal bone remodeling. In this condition, bones may become weakened and deformed due to the excessive breakdown and formation of bone tissue. Stoplos one 5 mg 100ml infusion helps to regulate the activity of osteoclasts, which are the cells responsible for bone resorption. By doing so, it reduces the risk of fractures and alleviates associated symptoms such as bone pain.
• Stoplos one 5 mg 100ml infusion plays a significant role in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This condition can lead to the production of abnormal antibodies, which may harm various organs. By using Stoplos one, healthcare professionals aim to manage the complications associated with multiple myeloma, such as bone pain and weakened immune function. This infusion helps improve the overall health and quality of life for affected individuals.
• Additionally, Stoplos one 5 mg 100ml infusion is effective in treating osteoporosis, a condition characterized by decreased bone density and increased fracture risk. By intervening in the bone resorption process, this infusion helps strengthen bones and reduce the likelihood of fractures. Patients with osteoporosis often experience pain and mobility issues, which Stoplos one aims to alleviate. This treatment is essential for maintaining bone health and preventing further deterioration in at-risk populations.
Benefits
Anti-bone-loss Drug Stoplos One contains zoledronic acid. Zoledronic acid is used to treat postmenopausal osteoporosis, Paget's disease, and hypercalcemia of malignancy (bone cancer in which there is an excess of calcium). This Zoledronic Acid Infusion 5 mg binds tightly to bone and prevents calcium removal by osteoclasts (a type of bone cell that destroys bone tissue). This prevents osteoclasts from breaking down the bone, strengthens the bone, and minimizes the risk of bone fractures. In addition, by preventing the reabsorption of calcium from the bones into the blood, Stoplos One 5 mg/100ml Infusion can reduce the level of calcium in the blood. This may help treat high blood calcium caused by cancer.
Side Effects
Like all medicines, Stoplos One 5 mg Vial may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Headache
• Back pain
• Musculoskeletal pain
• Heartburn
• Diarrhea
• Nausea
• Breathlessness
• Fatigue
• Constipation
• Bone pain
• Vomiting
• Fever
• Anemia
• Conjunctivitis
• Low phosphate
Common Side Effects
• Severe kidney problems
• Low calcium levels in the blood
How To Use
Stoplos One Infusion will be given by a doctor or nurse. How much you will be given and how often you will receive it will be decided by your doctor or nurse. It may be a single injection. Or you may need regular injections depending on your underlying condition. To avoid dehydration, your doctor will ask you to drink plenty of water before the injection. To get the full benefit of this medicine, it may take several days. This medicine is only part of a treatment program that may also include changes in your diet and the use of calcium and vitamin supplements.
Safety Advice
• Alcohol: Patients who are Anti-bone-loss Drug Stoplos One are advised to avoid drinking large amounts of alcohol, since heavy drinking may contribute to bone loss.
• Kidney: Use Zoledronic Acid Infusion 5 mg with caution, especially if you have a history of renal disease. The dose of Stoplos One 5 mg/100ml Infusion may be adjusted by your doctor if need be. If you have severe kidney problems, avoid taking Stoplos One 5 mg.
• Breastfeeding: It is unknown whether Stoplos One 5 mg is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Use Stoplos One 5 mg with caution, especially if you have a history of hepatic diseases/conditions. The dose may be adjusted by your doctor as needed.
• Pregnancy: No animal reproduction studies were performed on Stoplos One 5 mg/100ml Infusion. In general, Stoplos One 5 mg is not considered to be safe during pregnancy. It is important to discuss the potential risks and benefits of using Stoplos One 5 mg/100ml Infusion during pregnancy with your doctor if you are pregnant or planning to become pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Stoplos One 5 mg Vial may cause dizziness. Therefore, avoid driving or operating machinery if you feel dizzy after taking Stoplos One 5 mg.